Quarterly and annual results disclosed under 8-K Item 2.02.
Citi Trends Inc reported the fiscal year ended January 31, 2026 results: revenue $820.0 million, net income $5.2 million.
“FOURTH QUARTER AND FISCAL 2025 RESULTS Q4 2025 total sales of $230.4 million with comparable store sales growth of 8.9%; Two-year stack of 15.3% Fiscal 2025 total sales of $820.0 million with comparable store sales growth of 9.7%; Two-year stack of 13.1% Strong start to Q1 2026 with high-single digit comparable store sales increase Fiscal 2026 Outlook doubles”
Citi Trends Inc reported the fourth quarter ended January 31, 2026 results: revenue $230.4 million, net income $7.4 million.
“--- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 tm268989d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CITITRENDS ANNOUNCES FOURTH QUARTER AND FISCAL 2025 RESULTS Q4 2025 total sales of $230.4 million with comparable store sales growth of 8.9%; Two-year stack of 15.3% Fiscal 2025 total sales of $820.0 million with comparable store sales growth of 9.7%; Two-year stack of 13.1%”
INTELLIGENT PROTECTION MANAGEMENT CORP. reported the three months and year ended December 31, 2025 results: revenue $6,133,803, net income $(631,968).
“while optimizing expenses.” Financial Highlights: Q4 2025 and the Year Ended December 31, 2025 Three Months Ended December, 31 (unaudited) Change 2025 2024 $ % Total revenues $ 6,133,803 $ 279,879 5,853,924 2091.6 % Operating loss from continuing operations (819,791 ) (1,578,115 ) 758,324 48.1 % Net loss from continuing operations (631,968 ) (1,422,089 ) 790,121”
lululemon athletica inc. reported fiscal year 2026 results: revenue $11.350 billion to $11.500 billion, EPS $12.10 to $12.30. Guidance initiated.
“For 2026, the Company expects net revenue to be in the range of $11.350 billion to $11.500 billion, representing growth of 2% to 4%. Diluted earnings per share are expected to be in the range of $12.10 to $12.30 for the year.”
lululemon athletica inc. reported the first quarter of 2026 results: revenue $2.400 billion to $2.430 billion, EPS $1.63 to $1.68. Guidance initiated.
“For the first quarter of 2026, the Company expects net revenue to be in the range of $2.400 billion to $2.430 billion, representing growth of 1% to 3%. Diluted earnings per share are expected to be in the range of $1.63 to $1.68 for the quarter.”
lululemon athletica inc. reported the fiscal year ended February 1, 2026 results: revenue $11.1 billion, EPS $13.26.
“Full year revenue increased 5% to $11.1 billion. Diluted EPS of $13.26”
lululemon athletica inc. reported the fourth quarter of 2025 results: revenue $3.6 billion, EPS $5.01.
“Fourth quarter revenue increased 1% to $3.6 billion. Diluted EPS of $5.01”
HEALTHEQUITY, INC. reported the fourth quarter ended January 31, 2026 results: revenue $334.6 million, net income $49.7 million, EPS $0.58 per diluted share. Guidance raised.
“Revenue for the fourth quarter ended January 31, 2026 was $334.6 million”
HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2026 results: revenue $1.31 billion, net income $215.2 million, EPS $2.46 per diluted share. Guidance raised.
“Revenue for the fiscal year ended January 31, 2026 was $1.31 billion”
IZEA Worldwide, Inc. reported FY 2025 results: revenue $31.2 million, net income $42,326.
“FY 2025 Financial Summary Compared to FY 2024 • Revenue was $31.2 million, compared to $35.9 million; $3.4 million of the annual decline is Hoozu, which was divested in late 2024 • Revenue from core-enterprise accounts, which represent the majority of total revenue, grew above market growth rates in 2025 • Net income was $42,326 compared to a loss of $18.9 million, which included $6.9 million in one-time charges • Adjusted EBITDA* was $0.7 million, compared to a loss of $11.1 million”
IZEA Worldwide, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $6.1 million, net income Net loss totaled $1.2 million.
“Q4 2025 Financial Summary Compared to Q4 2024 • Revenue from ongoing operations was $6.1 million, compared to $9.8 million (excluding Hoozu) • Managed Services bookings declined 18.7% to $9.0 million from $11.0 million in the prior year period (excluding Hoozu), reflecting our shift toward larger, recurring enterprise accounts. Approximately half of the decline reflects non-core customer activity exited in 2025. • Total costs and expenses decreased 46% to $7.7 million, compared to $14.2 million • Net loss totaled $1.2 million, compared to a net loss of $4.6 million”
Trevi Therapeutics, Inc. reported for the quarter and year ended December 31, 2025 results: net income $42.8 million.
“For the year ended December 31, 2025, the Company reported a net loss of $42.8 million, compared to a net loss of $47.9 million in 2024.”
Cibus, Inc. reported financial results for fourth quarter and year ended December 31, 2025.
“On March 17, 2026, Cibus, Inc. (the “Company”) announced its financial results for the fourth quarter and year ended December 31, 2025, and provided a business update.”
Gossamer Bio, Inc. reported the quarter and fiscal year ended December 31, 2025 results: net income Net loss for the three months ended December 31, 2025, was $47.2 million, or $0.21 per share, compared to a net loss of, EPS Net loss for the three months ended December 31, 2025, was $47.2 million, or $0.21 per share, compared to a net loss of.
“On March 17, 2026 , Gossamer Bio, Inc. (the “Company”) issued a press release reporting its financial results for the quarter and fiscal year ended December 31, 2025.”
Kalaris Therapeutics, Inc. reported the year ended December 31, 2025 results: net income net loss was $43.4 million.
“On March 17, 2026, Kalaris Therapeutics, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the year ended December 31, 2025.”
BICYCLE THERAPEUTICS PLC reported financial results for the fourth quarter and full year ended December 31, 2025.
“On March 17, 2026, Bicycle Therapeutics plc (the “Company”) issued a press release announcing financial results for the fiscal quarter and the year ended December 31, 2025 and other business highlights.”
Vireo Growth Inc. reported the fourth fiscal quarter ended December 31, 2025 results: revenue $104.5 million.
“Vireo Growth Inc. Announces Fourth Quarter 2025 Results Q4 GAAP revenue of $104.5 million increased 317.7% year-over-year”
Academy Sports & Outdoors, Inc. updated its the fourth quarter and fiscal year ended January 31, 2026 guidance (initiated).
“On March 17, 2026, Academy Sports and Outdoors, Inc. (the “Company”) issued a press release announcing financial results for the fiscal year ended January 31, 2026.”
Bakkt, Inc. reported financial results for the full year ended December 31, 2025.
“On March 16, 2026 Bakkt, Inc. (the “Company”) issued a Shareholder Letter (the “Letter”) announcing its financial results for the the full year ended December 31, 2025.”
Monte Rosa Therapeutics, Inc. reported financial results for the fourth quarter and full year ended December 31, 2025.
“On March 17, 2026, Monte Rosa Therapeutics, Inc. (the "Company") announced its financial results for the quarter ended December 31, 2025.”
Energy Vault Holdings, Inc. reported financial results for the quarter and year ended December 31, 2025.
“On March 17, 2026, Energy Vault Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2025.”
PSQ Holdings, Inc. reported the year ended December 31, 2025 results: revenue $18.2 million, net income $36.6 million, EPS $0.81.
“Net revenue from continuing operations, which includes the fintech segment, for the year ended December 31, 2025 was $18.2 million compared to $10.1 million for the year ended December 31, 2024, an 81% increase compared to the full year 2024.”
PSQ Holdings, Inc. reported the quarter ended December 31, 2025 results: revenue $7.3 million, net income $11.8 million, EPS $0.25.
“Net revenue from continuing operations, which includes the financial technology (“fintech”) segment, for the quarter ended December 31, 2025 was $7.3 million compared to $3.5 million for the fourth quarter ended December 31, 2024, a 109% increase compared to the prior year period.”
Dragonfly Energy Holdings Corp. reported full year ended December 31, 2025 results: revenue $58.6 million, net income Net Loss of $(69.9) million, EPS $(14.80) per diluted share.
“Shareholders Targets Positive Adjusted EBITDA at $70 Million Annual Revenue Run Rate Fourth Quarter and Full Year 2025 Financial Highlights ● Net sales were $13.1 million and $58.6 million. ● OEM net sales were $8.1 million and $36.9 million. ● Gross Margin was 18.2% and 26.7%. ● Net Loss was $(45.0) million and $(69.9) million. ● Adjusted EBITDA was $(3.8)”
Dragonfly Energy Holdings Corp. reported fourth quarter ended December 31, 2025 results: revenue $13.1 million, net income Net Loss of $(45.0) million, EPS $(14.92) per diluted share.
“Alignment with Shareholders Targets Positive Adjusted EBITDA at $70 Million Annual Revenue Run Rate Fourth Quarter and Full Year 2025 Financial Highlights ● Net sales were $13.1 million and $58.6 million. ● OEM net sales were $8.1 million and $36.9 million. ● Gross Margin was 18.2% and 26.7%. ● Net Loss was $(45.0) million and $(69.9) million. ● Adjusted”
NEXTNAV INC. reported financial results for the twelve months ended December 31, 2025.
“On March 17, 2026 , NextNav Inc. issued a press release announcing its financial results for the twelve months ended December 31, 2025.”
KESTRA MEDICAL TECHNOLOGIES, LTD. reported the third quarter fiscal 2026, which ended January 31, 2026 results: revenue $24.6 million, net income $34.2 million. Guidance raised.
“and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026. Financial Highlights • Generated revenue of $24.6 million in Q3 FY26, an increase of 63% compared to the prior year period. • Expanded gross margin to 52.6% in Q3 FY26 compared to 43.4% in the prior year period. • Increased FY26 revenue”
AN2 Therapeutics, Inc. reported financial results for fourth quarter and year ended December 31, 2025.
“On March 17, 2026, AN2 Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter ended December 31, 2025.”
Fold Holdings, Inc. reported the fiscal year and fourth quarter ended December 31, 2025 results: revenue $31.8 million, EPS ($1.65) per share.
“these forward-looking statements. --- EX-99.1 (EX-99.1) --- EX-99.1 Fold Holdings, Inc. (NASDAQ: FLD) Announces Fourth Quarter and Full Year 2025 Results 2025 Revenue: $31.8 million, 34% YoY increase 2025 Transaction Volumes of $960 million, 46% YoY increase Launch of Fold Bitcoin Credit Card and Enterprise Services Retired convertible notes, Streamlined”
Expion360 Inc. reported fourth quarter and year ended December 31, 2025 results: revenue $9.7 million.
“Net sales for the year ended December 31, 2025 totaled $9.7 million, a 72% increase compared to $5.6 million for the same period in 2024.”
Andersen Group Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue Full-year revenue of $838.7 million, net income (net loss) for full-year 2025 of ($130.2) compared with net income of $134.8 million in 2024. Guidance initiated.
“ANDG) today released financial results for the fourth quarter and full year ended December 31, 2025. Andersen delivered strong top-line growth in 2025, with full-year revenue of $838.7 million, up 14.6% from $731.6 million in 2024. Fourth-quarter revenue of $170.3 million grew 19.6% year-over-year, compared with $142.4 million in the prior year period. Revenue growth”
Bob's Discount Furniture, Inc. reported fourth fiscal quarter and fiscal year ended December 28, 2025 results: revenue $648.8 million, net income $41.0 million, EPS $0.35.
“runway for growth, we are well-positioned to deliver sustainable value for our customers, team members, and shareholders.” Fourth Quarter of Fiscal Year 2025 • Net revenue of $648.8 million increased 8.2% from $599.8 million in the fourth quarter of fiscal year 2024 driven by new stores and comparable sales growth. • The Company opened three new stores and ended the”
ABEONA THERAPEUTICS INC. reported year ended December 31, 2025 results: revenue $5.8 million, net income $71.2 million, EPS $1.34 per basic and $1.01 per diluted common share.
“Abeona reported total revenue of $5.8 million for the year ended December 31, 2025.”
FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC. reported the fiscal quarter ended January 31, 2026 results: revenue Total real estate revenue increased 3.2% to approximately $7,504,000, net income Net income attributable to common equity ... was approximately $943,000 or $0.13 per share basic and diluted, EPS $0.13 per share basic and diluted.
“Per Share $0.10 $0.08 Total Average Residential Occupancy 95.5% 96.8% Total Average Commercial Occupancy 47.5% 48.2% Results for the Quarter Total real estate revenue increased 3.2% to approximately $7,504,000 for the fiscal quarter ended January 31, 2026 compared to approximately $7,269,000 for the prior year’s comparable period. The increase in revenue”
Lifeway Foods, Inc. reported the full year ended December 31, 2025 results: revenue $212.5 million, net income $13.9 million, or $0.91 per basic and $0.89 per diluted common share, EPS $0.89 per diluted common share. Guidance reaffirmed.
“99.1 Lifeway Foods ® Announces Strong Fourth Quarter and Record-Breaking Full Year 2025 Results Led by the Company’s Flagship Kefir Company achieves full year 2025 net sales of $212.5 million; up 19% year-over-year on a comparable basis Record-breaking year marks six years of uninterrupted, volume-led annual net sales growth Annual gross margin expansion of 140 basis”
Lifeway Foods, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $55.4 million, net income $2.5 million, or $0.17 per basic and $0.16 per diluted common share, EPS $0.16 per diluted common share.
“basis, representing our sixth consecutive year of strong volume-led growth. This outstanding performance was capped off by a very strong fourth quarter, with net sales of $55.4 million, up 18.0% year-over-year, and gross margin expansion of 250 basis points. Our disciplined execution drove significant gross margin expansion of 140 basis points for the full year”
Arena Group Holdings, Inc. reported the year ended December 31, 2025 results: revenue $134.8 million, net income $28.6 million.
“Full year revenue increased to $134.8 million in 2025 from $125.9 million in 2024 as the result of growth in our non-advertising revenue streams. Full year gross margin significantly expanded to 50.7% in 2025 compared to 44.2% in 2024. Income from continuing operations for 2025 was $28.6 million, up from a loss of $7.7 million in 2024.”
Arena Group Holdings, Inc. reported preliminary financial results for the quarter and year ended December 31, 2025.
“On March 17, 2026, The Arena Group Holdings, Inc. (the “Company”) posted to its investor relations website at https://investors.thearenagroup.net/events-and-presentations/presentations , as well as on its LinkedIn, Instagram and X (formerly known as Twitter) pages, a video presentation by Paul Edmondson, the Company’s Chief Executive Officer, discussing the Company’s business and financial results for the quarter and year ended December 31, 2025.”
Consolidated Water Co. Ltd. reported year ended December 31, 2025 results: revenue $132.1 million, net income $18.3 million, EPS $1.14 per diluted share.
“will hold a conference call at 11:00 a.m. Eastern time tomorrow to discuss the results (see dial-in information below). 2025 Financial Summary ● Total revenue decreased 1% to $132.1 million. ● Retail revenue increased 6% to $33.6 million. ● Bulk revenue decreased 1% to $33.5 million. ● Services revenue decreased by 9% to $46.3 million primarily due to a decline in”
LIFECORE BIOMEDICAL, INC. DE reported the transition period ended December 31, 2025 results: revenue $75.5 Million, net income $18.0 million.
“Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update -- Recorded Fourth Quarter Revenues of $35.7 Million and Transition Period Revenues of $75.5 Million -- -- Multiple New Programs Signed in Fourth Quarter 2025 Including Two Commercial Site Transfer Programs, for Total of Five New Programs in 2025 Transition Period -- --”
LIFECORE BIOMEDICAL, INC. DE reported the fourth quarter ended December 31, 2025 results: revenue $35.7 Million.
“Recorded Fourth Quarter Revenues of $35.7 Million and Transition Period Revenues of $75.5 Million”
WW INTERNATIONAL, INC. reported full year 2026 results: revenue $620 million to $635 million. Guidance initiated.
“Revenue guidance of $620 million to $635 million.”
Greystone Housing Impact Investors LP reported the year ended December 31, 2025 results: net income Net loss of $7.6 million or $0.52 per Beneficial Unit Certificate (“BUC”), basic and diluted, EPS $0.52 per BUC.
“The Partnership reported the following results for the year ended December 31, 2025: • Net loss of $7.6 million or $0.52 per Beneficial Unit Certificate (“BUC”), basic and diluted • Cash Available for Distribution (“CAD”) of $19.1 million or $0.82 per BUC”
Greystone Housing Impact Investors LP reported the three months ended December 31, 2025 results: net income Net loss of $2.6 million or $0.17 per Beneficial Unit Certificate (“BUC”), basic and diluted, EPS $0.17 per BUC.
“The Partnership reported the following results as of and for the three months ended December 31, 2025: • Net loss of $2.6 million or $0.17 per Beneficial Unit Certificate (“BUC”), basic and diluted • Cash Available for Distribution (“CAD”) of $2.8 million or $0.12 per BUC • Total assets of $1.5 billion • Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”) investments of $1.15 billion”
NATURAL GAS SERVICES GROUP INC updated its full year 2026 guidance (initiated).
“The Company is introducing the following guidance for the full year 2026: Outlook FY 2026 Adjusted EBITDA $90.5 million - $95.5 million”
NATURAL GAS SERVICES GROUP INC reported full year 2025 results: revenue $164.3 million, net income $19.9 million, EPS $1.57 per diluted share.
“fourth quarter of 2025 represents a 16.0% year-over-year increase and a 6.8% sequential increase compared to the third quarter of 2025. Rental revenue for the full year 2025 of $164.3 million represents a 13.9% increase compared to 2024. • Net income of $4.1 million, or $0.32 per diluted share, for the fourth quarter of 2025 compared to $2.9 million or $0.23 per”
NATURAL GAS SERVICES GROUP INC reported fourth quarter of 2025 results: revenue $46.1 million, net income $4.1 million, EPS $0.32 per diluted share.
“maintain that disciplined approach going forward. 2025 Fourth Quarter Financial Results Revenue: Total revenue for the three months ended December 31, 2025, increased 13.5% to $46.1 million from $40.7 million for the three months ended December 31, 2024. This increase was solely attributable to higher rental revenues for the comparable periods. Rental revenue”
AGENUS INC reported financial results for the full year ended December 31, 2025.
“On March 16, 2026, Agenus Inc. announced its financial results for the quarter and year ended December 31, 2025.”
AGENUS INC reported financial results for the fourth quarter ended December 31, 2025.
“On March 16, 2026, Agenus Inc. announced its financial results for the quarter and year ended December 31, 2025.”
W&T OFFSHORE INC reported financial results for full year 2025.
“W&T Offshore, Inc. (NYSE: WTI) (“W&T,” the “Company,” “we” or “us”) today reported final operational and financial results for the fourth quarter and full year 2025, including the Company’s year-end 2025 reserve report.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.